Tharimmune, Inc.
THAR
$1.17
-$0.005-0.43%
| Weiss Ratings | THAR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | THAR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | THAR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.25 | |||
| Price History | THAR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -17.02% | |||
| 30-Day Total Return | -17.02% | |||
| 60-Day Total Return | -42.93% | |||
| 90-Day Total Return | -52.24% | |||
| Year to Date Total Return | -42.93% | |||
| 1-Year Total Return | -82.26% | |||
| 2-Year Total Return | -99.62% | |||
| 3-Year Total Return | -99.77% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -82.66% | |||
| 52-Week Low % Change | 22.90% | |||
| Price | THAR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $6.75 | |||
| 52-Week Low Price | $0.95 | |||
| 52-Week Low Price (Date) | Apr 07, 2025 | |||
| 52-Week High Price (Date) | Apr 09, 2024 | |||
| Valuation | THAR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 2.47M | |||
| Enterprise Value | -1.09M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -9.89 | |||
| Earnings Per Share Growth | -94.79% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 1.77 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $1.17 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | 0.09 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | THAR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.79M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | THAR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 908 955 3140 | |||
| Address | 1200 Route 22 East Bridgewater, NJ 08807 | |||
| Website | www.tharimmune.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | THAR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | THAR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -105.96% | |||
| Return on Equity | -- | |||
| Income Statement | THAR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -12.43M | |||
| Net Income (TTM) | -12.20M | |||
| Net Income Avl. to Common (TTM) | -12.20M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -54.44% | |||
| EPS Diluted (TTM) | -9.89 | |||
| EPS Diluted Growth (Q YOY) | 79.99% | |||
| Balance Sheet | THAR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.56M | |||
| Cash Per Share (Q) | $1.99 | |||
| Total Current Assets (Q) | 3.72M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.31M | |||
| Current Ratio (Q) | 1.542 | |||
| Book Value Per Share (Q) | $0.66 | |||
| Total Assets (Q) | 3.72M | |||
| Total Current Liabilities (Q) | 2.41M | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 2.41M | |||
| Total Common Equity (Q) | 1.31M | |||
| Cash Flow | THAR - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 3.53M | |||
| Net Change in Cash (TTM) | -7.38M | |||
| Levered Free Cash Flow (TTM) | -6.60M | |||
| Cash from Operations (TTM) | -10.90M | |||
